Old Web
English
Sign In
Acemap
>
authorDetail
>
Wangjun Liao
Wangjun Liao
Medicine
Pathology
Internal medicine
Oxaliplatin
Gastroenterology
5
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
2019
Journal of Clinical Oncology
Rui Hua Xu
Zhi Qiang Wang
Lin Shen
Wei Wang
Jian-Wei Lu
Guanghai Dai
Jianming Xu
Yanqiao Zhang
Xiao-Bing Chen
Yanhong Deng
Yun-Bo Zhao
Nanfeng Fan
Gengsheng Yu
Wangjun Liao
Xia Yuan
You-En Lin
Guo Long Liu
Qing-Feng Zou
Show All
Source
Cite
Save
Citations (0)
S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
2019
Journal of Clinical Oncology
Rui Hua Xu
Zhi Qiang Wang
Lin Shen
Wei Wang
Jian-Wei Lu
Guanghai Dai
Jianming Xu
Yanqiao Zhang
Xiao-Bing Chen
Yanhong Deng
Yun-Bo Zhao
Nanfeng Fan
Gengsheng Yu
Wangjun Liao
Xia Yuan
Youen Lin
Guo Long Liu
Qingfeng Zou
Show All
Source
Cite
Save
Citations (0)
The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
2011
Biomedicine & Pharmacotherapy
Qiang Zuo
Min Shi
Jinzhang Chen
Wangjun Liao
Show All
Source
Cite
Save
Citations (8)
The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma
2011
Biomedicine & Pharmacotherapy
Qiang Zuo
Min Shi
Jinzhang Chen
Wangjun Liao
Show All
Source
Cite
Save
Citations (1)
Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours
2004
World Journal of Surgical Oncology
Shijun Kang
Rongcheng Luo
Wangjun Liao
Hubing Wu
Xuelin Zhang
Yuru Meng
Show All
Source
Cite
Save
Citations (58)
1